Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scars

J Cell Physiol. 2020 May;235(5):4109-4119. doi: 10.1002/jcp.29302. Epub 2019 Oct 14.

Abstract

Hypertrophic scars (HTS) commonly occurred after burn and trauma. It was characterized by the excessive deposition of extracellular matrix with the inadequate remodeling, which could result in severe physiological and psychological problems. However, the effective available prevention and treatment measures were still limited. The main pathological feature of HTS was the excessive formation of myofibroblasts, and they persist in the repaired tissue. To better understand the mechanics of this process, this review focused on the characteristics and formation of myofibroblasts, the main effector cells in HTS. We summarized the present theories and opinions on myofibroblasts formation from the perspective of related signaling pathways and epigenetic regulation, such as DNA methylation, miRNA/lncRNA/ceRNA action, histone modification, and so forth for a better understanding on the development of HTS. This information might assist in developing effective experimental and clinical treatment strategies. Additionally, we also summarized currently known clinical strategies for HTS treatment, including traditional drugs, molecular medicine, stem cells, and exosomes.

Keywords: epigenetic mechanism; extracellular matrix; hypertrophic scars; myofibroblast; stem cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cicatrix, Hypertrophic / drug therapy*
  • Epigenesis, Genetic
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Myofibroblasts / physiology*

Substances

  • MicroRNAs